Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Radius Health Inc (NASDAQ:RDUS)

54.54
Delayed Data
As of Aug 29
 +0.25 / +0.46%
Today’s Change
24.75
Today|||52-Week Range
77.10
-11.37%
Year-to-Date
3 Biotech Stocks With Explosive Upside Potential
Aug 23 / MotleyFool.com - Paid Partner Content
Radius (RDUS) Osteoporosis Drug Positive in Phase III Study
Aug 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close54.29
Today’s open54.58
Day’s range53.84 - 55.27
Volume715,960
Average volume (3 months)773,742
Market cap$2.3B
Dividend yield--
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)+36.63%
Earnings growth (this year)-60.50%
Earnings growth (next 5 years)-63.99%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.06

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics-0.11-0.63%
EXASExact Sciences Corp0.000.00%
ARIAARIAD Pharmaceutical...-0.04-0.39%
NVAXNovavax Inc+0.03+0.42%
Data as of 08/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.02
Annual revenue (last year)$0.00
Annual profit (last year)-$101.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert E. Ward
CFO, Secretary, Treasurer &
Senior Vice President
Brian Nicholas Harvey
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs